Grant: Operating Grant - Knowledge to Action Grants -CCSRI
University of Toronto
$37,755.00
Implementing lung cancer screening for those living with low income
EF 2017-18
Résumé
Lung cancer is currently the most common cause of cancer death in Canada. However, when detected early, fiveyear
recurrence-free rates of Stage 1A disease approach 80%+, whereas progressively later stages have
recurrence-free rates of 50% or less. Screening procedures look for abnormal changes that lead to biopsy and
subsequent definitive management, allowing treatment to be less invasive and more cost-effective. Early
screening for lung cancer using low-dose CT (LDCT) scanning can detect early stage cancers long before
symptoms appear. The initiation of LDCT screening has become widespread in many jurisdictions, particularly in
the United States. In Canada, population-wide implementation has not yet occurred, but Cancer Care Ontario is
currently piloting lung cancer screening at several sites in the province for people at high risk. Concerns around
screening include the potential harms (e.g. false positives), identifying the optimal group of at-risk individuals, and
the optimal frequency of screening. The most cost-effective program will need to screen the highest risk
individuals i.e. those with the highest smoking rates. However, the highest rates of smoking are often found
among those of low socioeconomic status (SES), a group that has usually been excluded from North American
screening studies. The effectiveness of lung cancer screening in a more disadvantaged population is not well
known. We do know that cervical, breast and colorectal cancer screening rates are reduced among Canadians
experiencing social disadvantage.
Programme
Operating Grant - Knowledge to Action Grants -CCSRI
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
378483
Name
Lofters Aisha K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Cancer Society - National Office (Toronto)
Instname2
Cancer Research
Theme2
Not applicable / Specified
Prcname2
Special Cases
Projecttitle
Implementing lung cancer screening for those living with low income
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$37,755
Cihrequipment2
$0
Programname2
Operating Grant - Knowledge to Action Grants -CCSRI
Keyworddelim
..
Abstract
Lung cancer is currently the most common cause of cancer death in Canada. However, when detected early, fiveyear
recurrence-free rates of Stage 1A disease approach 80%+, whereas progressively later stages have
recurrence-free rates of 50% or less. Screening procedures look for abnormal changes that lead to biopsy and
subsequent definitive management, allowing treatment to be less invasive and more cost-effective. Early
screening for lung cancer using low-dose CT (LDCT) scanning can detect early stage cancers long before
symptoms appear. The initiation of LDCT screening has become widespread in many jurisdictions, particularly in
the United States. In Canada, population-wide implementation has not yet occurred, but Cancer Care Ontario is
currently piloting lung cancer screening at several sites in the province for people at high risk. Concerns around
screening include the potential harms (e.g. false positives), identifying the optimal group of at-risk individuals, and
the optimal frequency of screening. The most cost-effective program will need to screen the highest risk
individuals i.e. those with the highest smoking rates. However, the highest rates of smoking are often found
among those of low socioeconomic status (SES), a group that has usually been excluded from North American
screening studies. The effectiveness of lung cancer screening in a more disadvantaged population is not well
known. We do know that cervical, breast and colorectal cancer screening rates are reduced among Canadians
experiencing social disadvantage.
Competitiondate
201706
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lofters, Aisha K
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $37,755~ $0~